Cytocares
About:
Cytocares offers innovative drug design for antibody novel medication creation and development in the realm of tumor immunity.
Website: http://www.cytocares.com
Top Investors: Shenzhen Capital Group, Tailong Investment, Jolmo Capital, Prosperico Ventures, Bossage Genetics
Description:
Cytocares offers innovative drug design for antibody novel medication creation and development in the realm of tumor immunity.
Total Funding Amount:
100M CNY
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Shanghai, Shanghai, China
Founded Date:
2015-12-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2023-05-17
IPO Status:
Private
Industries:
© 2025 bioDAO.ai